Nausea typically emerges as the leading symptom, often accompanied by mild stomach discomfort or loss of appetite
Nat Rev Neurosci 13:7793 Shutt TE, McBride HM (2013) Staying cool in difficult times: mitochondrial dynamics, quality control and the stress response
By maintaining partnerships with established 503A compounders, PlexusDx ensures patients can access proven GLP-1 therapy without disruption from supply volatility or regulatory changes that do not affect legitimate compounding operations
Quick Answer: Semaglutide can cause localized injection site reactions in approximately 1.42.4% of patients, and rare serious hypersensitivity reactions including rash and angioedema have been reported, though widespread skin sensitivity is not a common side effect
Faster dose increases led to higher rates of nausea (up to 60% versus 44% with standard titration), more vomiting, and significantly higher protocol discontinuation rates
However, only a small proportion of pharmacologic treatments evaluated in phase II progress to phase III and even fewer progress to market